The primary aim is to establish the percentage of patients with unknown (pre )diabetes in the group of patients who present with a trigger finger. Our secondary objective is to relate the outcomes of treatment to the presence of diabetes.
ID
Source
Brief title
Condition
- Tendon, ligament and cartilage disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Prevalence of (undiagnosed) (pre-)diabetes
Secondary outcome
Outcomes of the treatment.
Patient reported:
Q-DASH (Quick DASH-DLV)
Satisfaction (Patient Satisfaction, van Lankveld et al. 2000, JHS)
VAS pain scale
Function:
Range of motion
Precence of a "click"
Background summary
It is known that people with diabetes have a greater chance of developing a
trigger finger. This known relationship between trigger finger and diabetes
suggests that patients who present with a trigger finger, have an increased
risk to be diabetic or pre-diabetic. A fraction of this patient group may have
unknown diabetes.
Our question is whether there is a substantial number of patients with
undiagnosed (pre )diabetes in the group of patients who present with a trigger
finger.
Study objective
The primary aim is to establish the percentage of patients with unknown (pre
)diabetes in the group of patients who present with a trigger finger. Our
secondary objective is to relate the outcomes of treatment to the presence of
diabetes.
Study design
This is a retrospective and prospective observational study.
Study burden and risks
Burden:
read information letter and fill out consent form.
A finger prick (when inconclusive, a second blood test is done).
Filling out three very short questionnaires.
Risk: Negligible
Boelelaan 1117
Amsterdam 1081 HV
NL
Boelelaan 1117
Amsterdam 1081 HV
NL
Listed location countries
Age
Inclusion criteria
Patients who presented with a trigger finger at the outpatient clinic of the VUmc or The Hand Clinic in 2012 are eligible for this study.
Patients are 18 years or older
Patients are treated within 6 months after diagnosis with Kenacort injection (once or twice), surgery or a combination of these therapies.
Exclusion criteria
Time between diagnosis and last treatment is longer than 6 months
History of/or current serious concomitant disease (i.e. macrovascular, liver, renal, untreated thyroid, malignancy);
Pregnancy;
Substance and/or alcohol abuse;
Unable to fill in and complete informed consent and questionnaire.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL44530.029.13 |